Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | ICICI Pru |
| AUM | ₹1,534 Cr | ₹15,842 Cr |
| NAV | ₹38.9215 | ₹27.8400 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 5.8 years |
| Expense ratio | 1.1% | 1.0% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 79.20 |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| 1 month | — | +11.58% |
| 3 months | — | +4.70% |
| 6 months | — | +8.33% |
| YTD | — | +2.02% |
| 1 year | — | +1.64% |
| 3 years (CAGR) | — | +16.92% |
| 5 years (CAGR) | — | +16.09% |
| 10 years (CAGR) | — | — |
| Since launch | — | +19.15% |
Risk
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Volatility | — | 15.4% |
| Downside volatility | — | 9.7% |
| Sharpe | — | 0.68 |
| Sortino | — | 1.07 |
| Calmar | — | 1.18 |
| Return / risk | — | 1.10 |
| Deepest fall | — | −14.39% |
| Days to recover | — | 101 |
| Below its high | — | 0.00% |
Against benchmark
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Alpha | — | +4.27% |
| Beta | — | 0.92 |
| R² | — | 92.0% |
| Up capture | — | 103.3% |
| Down capture | — | 80.8% |
| Tracking error | — | 4.6% |
| Information ratio | — | 0.83 |
| Treynor | — | 0.10 |
Consistency
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Best 1-year | — | +57.85% |
| Middle 1-year | — | +14.06% |
| Worst 1-year | — | −9.72% |
| 1-year periods with a loss | — | 4.1% |
| Middle 3-year | — | +23.35% |
| Positive months | — | 61.1% |
| Best day | — | +4.49% |
| Worst day | — | −5.43% |
| Worst 5% day | — | −1.26% |
| Positive days | — | 54.8% |
| NAVs a year | — | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| 5-year XIRR | — | +15.82% |
| 5-year value | — | ₹8,98,335 |
| 3-year XIRR | — | +10.13% |
| 1-year XIRR | — | +10.49% |
Holdings overlap i
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Tata India Pharma & Healthcare Fund Direct · filing Oct 2026 | — | 0% |
| ICICI Prudential Business Cycle Fund Direct · filing Oct 2026 | 0% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata India Pharma & Healthcare Fund and ICICI Prudential Business Cycle Fund
Overlap
0.5%
smaller weight of each shared stock, added up
Stocks in common
1
of 39 and 74
Weight in common
0% · 0%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | Counts toward overlap |
|---|---|---|---|
| PI Industries Limited | 0.46% | 0.50% | 0.46% |
| 1 stocks | 0.5% | 0.5% | 0.5% |
Only in Tata India Pharma & Healthcare Fund (38)
| Sun Pharmaceutical Industries Limited | 7.89% |
| Abbott India Limited | 5.66% |
| Divi's Laboratories Limited | 5.41% |
| Healthcare Global Enterprises Limited | 5.25% |
| Dr. Reddy's Laboratories Limited | 5.14% |
| Torrent Pharmaceuticals Limited | 4.73% |
| Apollo Hospitals Enterprise Limited | 4.55% |
| Max Healthcare Institute Limited | 4.28% |
| Rainbow Childrens Medicare Limited | 4.02% |
| Sai Life Sciences Limited | 3.22% |
| Syngene International Limited | 3.17% |
| Procter & Gamble Health Limited | 3.15% |
| Lupin Limited | 3.13% |
| Cipla Limited | 3.08% |
| Anthem Biosciences Limited | 2.99% |
| Natco Pharma Limited | 2.86% |
| FDC Limited | 2.69% |
| Bayer Cropscience Limited | 2.68% |
| Acutaas Chemicals Limited | 2.40% |
| Pfizer Limited | 2.40% |
| Aster DM Quality Care Limited | 2.33% |
| Biocon Limited | 2.23% |
| Navin Fluorine International Limited | 2.15% |
| Sanofi Consumer Healthcare India Limited | 1.99% |
| Ajanta Pharma Limited | 1.59% |
and 13 smaller holdings (10.3% of the fund).
Only in ICICI Prudential Business Cycle Fund (73)
| HDFC Bank Limited | 9.53% |
| ICICI Bank Limited | 7.22% |
| Reliance Industries Limited | 5.31% |
| Kotak Mahindra Bank Limited | 3.76% |
| Mahindra & Mahindra Limited | 3.73% |
| Maruti Suzuki India Limited | 3.41% |
| Bharti Airtel Limited | 3.40% |
| DLF Limited | 3.07% |
| HDFC Life Insurance Company Limited | 3.02% |
| Larsen & Toubro Limited | 2.93% |
| UltraTech Cement Limited | 2.84% |
| Xtrackers Harvest CSI 300 China A-Shares ETF | 2.75% |
| Hero MotoCorp Limited | 2.45% |
| NTPC Limited | 2.33% |
| InterGlobe Aviation Limited | 2.23% |
| Prestige Estates Projects Limited | 1.94% |
| Asian Paints Limited | 1.78% |
| SBI Life Insurance Company Limited | 1.67% |
| Axis Bank Limited | 1.46% |
| Trent Limited | 1.42% |
| Info Edge (India) Limited | 1.40% |
| ICICI Lombard General Insurance Company Limited | 1.34% |
| Hyundai Motor India Ltd | 1.18% |
| Shree Cement Limited | 1.16% |
| Hindustan Petroleum Corporation Limited | 0.99% |
and 48 smaller holdings (16.2% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata India Pharma & Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Large companies | 26.8% | 65.3% |
| Mid companies | 30.4% | 14.2% |
| Small companies | 40.2% | 6.5% |
| Top 10 holdings | 50.1% | 45.4% |
| Largest sector | Pharmaceuticals & Biotechnology 64% | Banks 22% |